First NIH study using NADMED technology out in October

First NIH study using NADMED technology out in October

NADMED method has been used to detect NAD levels in muscle myopathy study conducted by several renowned parties namely NIH, National Institute of Nursing Research, University of Rochester Medical Center, National Institute of Neurological Disorders and Stroke, Biogen...
NADMED in NYC EARD 2023 Summit

NADMED in NYC EARD 2023 Summit

NADMED attends this year’s Ending Age Related Diseases summit in New York 10-11th August. If you wish to hear the latest news about NAD and NAD measuring come to meet us and let’s have a cup of coffee. Write to kai.herdin@nadmed.com and book a meeting. The...
Recognition for NADMED technology

Recognition for NADMED technology

NADMED is one of ten companies chosen for the Deep Tech Accelerator Funding program. The companies selected in the program aim at high social impact and seek to solve major global problems and have been founded to commercialize the latest research results and...
Meet NADMED at EUROMIT 2023

Meet NADMED at EUROMIT 2023

NADMED attends the premier international conference on mitochondrial disease EUROMIT 11-15 June. The prestigious five-day event will host talks from globally renowned experts in the mitochondrial field, an exceptional opportunity to share information about the study...